Relmada Therapeutics Inc (NAS:RLMD) Stock News, Headlines & Updates
Relmada Therapeutics Inc Stock News from GuruFocus
- 1
Aug 08, 2024
Relmada Therapeutics Inc (RLMD) Q2 2024 Earnings Call Transcript Highlights: Improved Financial Management and Clinical Progress
GuruFocus Research • 1:10am
Q2 2024 Relmada Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:33pm
Aug 07, 2024
Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
PRNewswire • 4:01pm
Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Marketwired • 4:00pm
Aug 05, 2024
Relmada Therapeutics to Report Second Quarter 2024 Financial Results on August 7, 2024
Marketwired • 7:00am
Jul 25, 2024
Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm
PRNewswire • 2:00pm
Jun 18, 2024
Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry
PRNewswire • 8:00am
Jun 10, 2024
Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PRNewswire • 7:00am
Jun 03, 2024
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
PRNewswire • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news